Abstract B176: Synergistic induction of apoptosis by the histone‐deacetylase inhibitor, Panobinostat, combined with ABT‐737 or rhTRAIL, in multiple myeloma

2009 ◽  
Author(s):  
Geoffrey M. Matthews ◽  
Jake Shortt ◽  
Kellie M. Banks ◽  
Kym Stanley ◽  
David Faulkner ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Synergistic Induction ◽  
Induction Of Apoptosis

scholarly journals Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

Cancer ◽  
2010 ◽  
Vol 117 (2) ◽  
pp. 336-342 ◽  
Author(s):  
Ruben Niesvizky ◽  
Scott Ely ◽  
Tomer Mark ◽  
Sangeeta Aggarwal ◽  
Janice L Gabrilove ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Phase 2 ◽  
Refractory Multiple Myeloma ◽  
Phase 2 Trial ◽  
Deacetylase Inhibitor

Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344

2020 ◽  
Vol 160 ◽  
pp. 105076
Author(s):  
Mona Dawood ◽  
Edmond Fleischer ◽  
Anette Klinger ◽  
Gerhard Bringmann ◽  
Letian Shan ◽  
...  
Keyword(s):  
Cell Migration ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Class Ii ◽  
Deacetylase Inhibitor ◽  
Induction Of Apoptosis
Sign in / Sign up

Export Citation Format

Share Document